We are live on ! Find out more
VOYA Investment Management

VOYA Investment Management Portfolio holdings

AUM $96.1B
1-Year Est. Return 40.06%
This Fund
S&P 500
This Quarter Est. Return
+12.86%
1 Year Est. Return
+40.06%
3 Year Est. Return
+122.14%
5 Year Est. Return
+169.19%
10 Year Est. Return
+659.21%
AUM
$97.1B
AUM Growth
+$6.65B
Cap. Flow
-$14.9B
Cap. Flow %
-15.37%
Top 10 Hldgs %
21.87%
Holding
2,959
New
64
Increased
1,030
Reduced
1,426
Closed
61

Sector Composition

Rank Sector Weight
1 Technology 32.22%
2 Consumer Discretionary 10.51%
3 Healthcare 10.31%
4 Financials 7.48%
5 Industrials 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLTR icon
2676
Kaltura
KLTR
$249M
$71.1K ﹤0.01%
36,476
QUAD icon
2677
Quad
QUAD
$505M
$70.9K ﹤0.01%
13,085
-393
-3% -$1.92K
GLUE icon
2678
Monte Rosa Therapeutics
GLUE
$1.36B
$70.4K ﹤0.01%
12,465
-80,365
-87% -$315K
HRTX icon
2679
Heron Therapeutics
HRTX
$60.6M
$70.3K ﹤0.01%
41,355
NVTA
2680
DELISTED
Invitae Corporation
NVTA
$69K ﹤0.01%
110,067
TPIC
2681
DELISTED
TPI Composites
TPIC
$68K ﹤0.01%
16,434
ALDX icon
2682
Aldeyra Therapeutics
ALDX
$91.1M
$67.9K ﹤0.01%
19,334
BKSY icon
2683
BlackSky Technology
BKSY
$1.25B
$67.3K ﹤0.01%
6,009
RMNI icon
2684
Rimini Street
RMNI
$448M
$67.2K ﹤0.01%
20,553
TDUP icon
2685
ThredUp
TDUP
$416M
$65.6K ﹤0.01%
29,144
NAUT icon
2686
Nautilus Biotechnolgy
NAUT
$115M
$64.1K ﹤0.01%
21,426
SEAT icon
2687
Vivid Seats
SEAT
$86.8M
$63.6K ﹤0.01%
504
BFLY icon
2688
Butterfly Network
BFLY
$2.52B
$63.1K ﹤0.01%
58,396
BKKT icon
2689
Bakkt Inc
BKKT
$341M
$62.6K ﹤0.01%
+1,123
New +$38.9K
CMPX icon
2690
Compass Therapeutics
CMPX
$398M
$61.7K ﹤0.01%
39,556
LCTX icon
2691
Lineage Cell Therapeutics
LCTX
$283M
$61.7K ﹤0.01%
56,595
PDSB icon
2692
PDS Biotechnology
PDSB
$14.6M
$59.8K ﹤0.01%
12,037
+799
+7% +$3.97K
BLUE
2693
DELISTED
bluebird bio
BLUE
$59.6K ﹤0.01%
2,158
-19
-0.9% -$1.16K
TNYA icon
2694
Tenaya Therapeutics
TNYA
$171M
$59.6K ﹤0.01%
18,385
STOK icon
2695
Stoke Therapeutics
STOK
$2.13B
$58.8K ﹤0.01%
11,175
AVAH icon
2696
Aveanna Healthcare
AVAH
$1.92B
$58.6K ﹤0.01%
+21,859
New +$41.7K
LXRX icon
2697
Lexicon Pharmaceuticals
LXRX
$1.09B
$57.2K ﹤0.01%
37,359
MCRB icon
2698
Seres Therapeutics
MCRB
$46.5M
$56.7K ﹤0.01%
2,027
ATNM icon
2699
Actinium Pharmaceuticals
ATNM
$25M
$56K ﹤0.01%
11,014
BIRD icon
2700
Smartbird Inc
BIRD
$31.2M
$55.6K ﹤0.01%
2,268
+81
+4% +$1.6K

Similar funds

VOYA Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, VOYA Investment Management held 2,959 positions worth $97.1B, up 7.4% from $90.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

VOYA Investment Management withdrew a net $14.9B in Q4 2023, closing 61 positions and reducing 1,426 holdings. Its most notable exit was Activision Blizzard, an estimated $80.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, VOYA Investment Management opened a new position in Vanguard Short-Term Corporate Bond ETF worth $51.1M.

  • VOYA Investment Management's largest Q4 2023 buy was Vanguard Short-Term Corporate Bond ETF: 660,477 shares worth $51.1M.
  • VOYA Investment Management added most to First Solar in Q4 2023, an estimated $259M increase.
  • VOYA Investment Management's biggest Q4 2023 reduction was Apple, cutting an estimated $480M.
  • VOYA Investment Management fully exited Activision Blizzard in Q4 2023, selling an estimated $80.8M.
  • VOYA Investment Management's ten largest holdings make up 22% of its $97.1B portfolio in Q4 2023.
  • VOYA Investment Management opened 64 new positions and closed 61 in Q4 2023.
  • VOYA Investment Management's portfolio value rose 7.4% quarter-over-quarter to $97.1B.

Based on VOYA Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.